Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1007
-
Total 13F shares, excl. options
-
259M
-
Shares change
-
+5.22M
-
Total reported value, excl. options
-
$22.3B
-
Value change
-
+$464M
-
Put/Call ratio
-
0.7
-
Number of buys
-
433
-
Number of sells
-
-402
-
Price
-
$86.16
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q3 2018
1,078 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q3 2018.
NOVARTIS AG - Ordinary Shares (NVS) has 1,007 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 259M shares
of 2.18B outstanding shares and own 11.89% of the company stock.
Largest 10 shareholders include DODGE & COX (44.4M shares), PRIMECAP MANAGEMENT CO/CA/ (22.2M shares), FRANKLIN RESOURCES INC (15.1M shares), WELLS FARGO & COMPANY/MN (7.66M shares), BROWN BROTHERS HARRIMAN & CO (7.52M shares), Fisher Asset Management, LLC (7.43M shares), LOOMIS SAYLES & CO L P (7.35M shares), BANK OF AMERICA CORP /DE/ (7.24M shares), UBS Group AG (6.67M shares), and Boston Partners (5.59M shares).
This table shows the top 1007 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.